within Pharmacolibrary.Drugs.N_NervousSystem.N01A_AnestheticsGeneral.N01AX14_Esketamine;
model Esketamine 
   extends Pharmacolibrary.Drugs.ATC.N.N01AX14;

  annotation(Documentation(
    info ="<html><body><p>Esketamine is the S-enantiomer of ketamine, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist. It is used as an anesthetic agent and, more recently, as an antidepressant for treatment-resistant depression. Esketamine nasal spray is approved for use in adults with treatment-resistant depression in combination with another oral antidepressant.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic model parameters obtained from healthy adult subjects after single-dose intravenous administration.</p><h4>References</h4><ol><li><p>Čižmáriková, R, et al., &amp; Markulia, M (2023). General intravenous anesthetics - pharmacodynamics, pharmacokinetics and chiral properties. <i>Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti</i> 72(4) 155–164. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37805261/&quot;>https://pubmed.ncbi.nlm.nih.gov/37805261</a></p></li><li><p>Perez-Ruixo, C, et al., &amp; Perez-Ruixo, JJ (2021). Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression. <i>Clinical pharmacokinetics</i> 60(4) 501–516. DOI:<a href=&quot;https://doi.org/10.1007/s40262-020-00953-4&quot;>10.1007/s40262-020-00953-4</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33128208/&quot;>https://pubmed.ncbi.nlm.nih.gov/33128208</a></p></li><li><p>DeBattista, C, &amp; Schatzberg, AF (2024). The Black Book of Psychotropic Dosing and Monitoring. <i>Psychopharmacology bulletin</i> 54(3) 8–59. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38993656/&quot;>https://pubmed.ncbi.nlm.nih.gov/38993656</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Esketamine;
